BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 60 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year BIM was profitable.
BIM had a positive operating cash flow in the past year.
Each year in the past 5 years BIM has been profitable.
Each year in the past 5 years BIM had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 7.49%, BIM is doing good in the industry, outperforming 78.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.28%, BIM is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
BIM has a Return On Invested Capital of 9.33%. This is in the better half of the industry: BIM outperforms 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BIM is in line with the industry average of 8.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.49% | ||
| ROE | 10.28% | ||
| ROIC | 9.33% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
1.3 Margins
BIM has a Profit Margin of 10.86%. This is in the better half of the industry: BIM outperforms 73.33% of its industry peers.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
BIM's Operating Margin of 14.79% is fine compared to the rest of the industry. BIM outperforms 75.00% of its industry peers.
BIM's Operating Margin has improved in the last couple of years.
BIM's Gross Margin of 55.66% is in line compared to the rest of the industry. BIM outperforms 51.67% of its industry peers.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.79% | ||
| PM (TTM) | 10.86% | ||
| GM | 55.66% |
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIM is still creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
The number of shares outstanding for BIM has been reduced compared to 5 years ago.
The debt/assets ratio for BIM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.80 indicates that BIM is not in any danger for bankruptcy at the moment.
BIM has a better Altman-Z score (6.80) than 91.67% of its industry peers.
The Debt to FCF ratio of BIM is 1.53, which is an excellent value as it means it would take BIM, only 1.53 years of fcf income to pay off all of its debts.
BIM has a better Debt to FCF ratio (1.53) than 85.00% of its industry peers.
BIM has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BIM (0.08) is better than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.53 | ||
| Altman-Z | 6.8 |
ROIC/WACC1.2
WACC7.75%
2.3 Liquidity
BIM has a Current Ratio of 2.20. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
BIM has a better Current ratio (2.20) than 65.00% of its industry peers.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.29, BIM perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
BIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.01%, which is quite impressive.
BIM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.91% yearly.
The Revenue has grown by 8.31% in the past year. This is quite good.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
3.2 Future
Based on estimates for the next years, BIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.37% on average per year.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 6.35% on average per year.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 30.83 indicates a quite expensive valuation of BIM.
Based on the Price/Earnings ratio, BIM is valued a bit cheaper than 65.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, BIM is valued at the same level.
With a Price/Forward Earnings ratio of 25.66, BIM can be considered very expensive at the moment.
BIM's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.49, BIM is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.83 | ||
| Fwd PE | 25.66 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 66.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 63.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 43.81 | ||
| EV/EBITDA | 15.68 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 15.21% in the coming years.
PEG (NY)1.53
PEG (5Y)2.83
EPS Next 2Y16.12%
EPS Next 3Y15.21%
5. Dividend
5.1 Amount
With a yearly dividend of 0.75%, BIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.31, BIM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.43, BIM's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
5.2 History
The dividend of BIM is nicely growing with an annual growth rate of 19.40%!
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
23.18% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPA:BIM (6/27/2025, 7:00:00 PM)
119
-0.7 (-0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap14.08B
Analysts75.29
Price Target127.5 (7.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.57%
PT rev (3m)-1.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.83 | ||
| Fwd PE | 25.66 | ||
| P/S | 3.54 | ||
| P/FCF | 43.81 | ||
| P/OCF | 21.11 | ||
| P/B | 3.35 | ||
| P/tB | 4.72 | ||
| EV/EBITDA | 15.68 |
EPS(TTM)3.86
EY3.24%
EPS(NY)4.64
Fwd EY3.9%
FCF(TTM)2.72
FCFY2.28%
OCF(TTM)5.64
OCFY4.74%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.53
PEG (5Y)2.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.49% | ||
| ROE | 10.28% | ||
| ROCE | 12.7% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.83% | ||
| ROICexgc | 13.6% | ||
| OM | 14.79% | ||
| PM (TTM) | 10.86% | ||
| GM | 55.66% | ||
| FCFM | 8.08% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.53 | ||
| Debt/EBITDA | 0.39 | ||
| Cap/Depr | 106.34% | ||
| Cap/Sales | 8.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.01% | ||
| Profit Quality | 74.39% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 6.8 |
F-Score7
WACC7.75%
ROIC/WACC1.2
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.07%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%